Injectable Drug Delivery Market is Expected to Reach $866.31 Billion by 2022
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
According to Stratistics MRC, the Global Injectable Drug Delivery market is accounted for $348.64 billion in 2015 and is expected to reach $866.31 billion by 2022 growing at a CAGR of 13.9%. Rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices are some of the factors proliferating market demand. However, factors such as needle-stick injuries and lack of access to or failure to use appropriate personal protective equipment are some factors inhibiting the market. Browse the report: http://www.orbisresearch.com/reports/index/injectable-drug-deliveryglobal-market-outlook-2016-2022 Oncology and Hormonal disorder segment among therapeutic applications is expected to dominate the market owing to the rising number of patients suffering from diabetes and oncologic disorders. Moreover, self-injection device segment in product type is estimated to be the fastest growing segment on account of growing geriatric people coupled with diabetic patients. North American market is estimated to be the dominant among others attributed to its huge patient base and healthcare sector. Asia Pacific is expected to be the fastest growing market on account of its emerging healthcare sector. Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter International, Inc., Becton, Dickinson and Company, Elcam Medical, ELI Lilly and Company, Gerresheimer AG, Novo Nordisk, Pfizer, Inc., Sandoz, Schott AG, Terumo Corporation and Teva Pharmaceutical Industries Ltd. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/223186 Therapeutic Applications Covered: Autoimmune Diseases Crohn’s Disease Multiple Sclerosis Psoriasis Rheumatoid Arthritis Other Autoimmune Diseases Hormonal Disorders Anaemia Antithrombotic/Thrombolytic Therapy Diabetes Growth Hormone Deficiency (GHD) Osteoporosis Reproductive Health Disease Orphan Diseases Oncology Other Therapeutic Applications Pain Management Allergy Treatment www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Aesthetic Treatments Hepatitis C Haemophilia End-Users Covered: Home Care Settings Hospitals and Clinics Pharmaceutical and Biotechnology Companies Research Laboratories Other End Users Types Covered: Auto-injectors Reusable Auto-injectors Disposable Auto-injectors Product Specific Auto-injectors Pen Injectors Custom Pen Designs Disposable Pens Dual Chamber Pens Prefilled Pen Cartridges Standardized Pen Platforms Needle-free Injectors Mass Immunization Injectors Prefilled Disposable Models Refillable Cartridge Designs Energy Source Jet-Based Needle-Free Injectors Spring-Based Needle-Free Injectors Laser-Powered Needle-Free Injectors Vibration-Based Needle-Free Injectors Prefilled Syringes Plastic Prefilled Syringes Glass Prefilled Syringes Pre-fillable Safety Syringes Safety Syringes Pre-fillable Integrated Safety Syringes Non-Pre-fillable Integrated Safety Syringes onventional Injection Devices Formulations Covered: Novel Drug Delivery Formulations Colloidal Dispersions Micro particles Long-Acting Injection Formulations www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Conventional Drug Delivery Solutions Reconstituted/Lyophilized Formulations Suspensions Emulsions Modes of Administration Covered: Central Nervous System Circulatory/Musculoskeletal Organs Skin Usage Patterns Covered: Curative Care Immunization Other Usage Patterns Blood Transfusion & Blood Products Contraceptives Regions Covered: North America US Canada Mexico Europe Germany France Italy UK Spain Rest of Europe Asia Pacific Japan China India Australia New Zealand Rest of Asia Pacific Rest of the World Middle East Brazil Argentina South Africa Egypt www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements Major Points From The Table Of Contents: 1 Global Injectable Drug Delivery Market Outlook, By Region 2 Global Injectable Drug Delivery Market Outlook, By Therapeutic Application 3 Global Injectable Drug Delivery Market Outlook, By Autoimmune Diseases 4 Global Injectable Drug Delivery Market Outlook, By Crohn’s Disease 5 Global Injectable Drug Delivery Market Outlook, By Multiple Sclerosis 6 Global Injectable Drug Delivery Market Outlook, By Psoriasis 7 Global Injectable Drug Delivery Market Outlook, By Rheumatoid Arthritis 8 Global Injectable Drug Delivery Market Outlook, By Other Autoimmune Diseases 9 Global Injectable Drug Delivery Market Outlook, By Hormonal Disorders 10 Global Injectable Drug Delivery Market Outlook, By Anaemia 11 Global Injectable Drug Delivery Market Outlook, By Antithrombotic/Thrombolytic Therapy 12 Global Injectable Drug Delivery Market Outlook, By Diabetes 13 Global Injectable Drug Delivery Market Outlook, By Growth Hormone Deficiency (GHD) 14 Global Injectable Drug Delivery Market Outlook, By Osteoporosis 15 Global Injectable Drug Delivery Market Outlook, By Reproductive Health Disease
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
16 Global Injectable Drug Delivery Market Outlook, By Orphan Diseases 17 Global Injectable Drug Delivery Market Outlook, By Oncology 18 Global Injectable Drug Delivery Market Outlook, By Other Therapeutic Applications 19 Global Injectable Drug Delivery Market Outlook, By Pain Management 20 Global Injectable Drug Delivery Market Outlook, By Allergy Treatment About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A. Phone No.: +1 (214) 884-6817; +9164101019 Email: sales@orbisresearch.com
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019